Login / Signup

A severe case of reactive infectious mucocutaneous eruption associated with two possible triggers: Coronavirus and group A streptococcus.

Ivan RodriguezAndrew T KwongMinnelly LuuScott D Worswick
Published in: Pediatric dermatology (2024)
Reactive infectious mucocutaneous eruption (RIME) is a newly defined condition characterized by mucocutaneous blistering secondary to upper respiratory infections and encompasses Mycoplasma pneumoniae-induced rash and mucositis, broadening the disease spectrum to include various infectious etiologies. We present a severe RIME case involving a 5-year-old female with concurrent coronavirus NL63 and group A streptococcus infections. Diagnosis complexity stemmed from overlapping clinical features with other severe mucocutaneous eruptions such as Stevens-Johnson syndrome/toxic epidermal necrolysis/drug-induced necrolysis. This case underscores the need for comprehensive infectious workup and emphasizes the clinical diagnostic spectrum of drug-induced and infection-induced desquamative skin and mucosal disease.
Keyphrases
  • drug induced
  • liver injury
  • sars cov
  • biofilm formation
  • adverse drug
  • respiratory tract
  • candida albicans
  • squamous cell carcinoma
  • early onset
  • radiation induced
  • staphylococcus aureus
  • radiation therapy